Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Genomenon announced it raised $6.03 Million in an initial filing from an offering of $10 Million

PRIVATEJul 30, 2026•10 days ago

Amount Raised

$6.03 Million

Round Type

Venture - Series Unknown

Ann ArborBiotechnologyHardwareresearch

Company Information

Company

Genomenon, Inc.

Location

3135 S. STATE STREET

Ann Arbor, Michigan, United States

About

Genomenon is a genomics intelligence company dedicated to improving the quality of life of genetic disease and cancer patients by making genomic information actionable. Blending the power of AI with the precision of genomic expertise, the company empowers pharmaceutical companies and the clinical diagnostic community with empirical genomic evidence and insights that both support the development of novel therapeutics and speed diagnostic assessments and treatment recommendations.

Related People

Suggested for you
4 contacts
Verified contactsMike K., Chief Executive Officer hidden hidden hidden
Predictive Intelligence
Strategic

ML-powered predictions for Genomenon, Inc.'s next move

Learn about Strategic plan

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.